Nuklearmedizin - NuclearMedicine · 2007 · 78 citations · 10 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic RadiologyGenitourinary RadiologyBone Metastasis ImagingMetastatic Bone DiseaseProstate CancerProstate Cancer ImagingProstate ImagingProstate-specific Antigen TestingAdrenal Tumor StagingLocal Tumor StagingLymph Node MetastasesProstate Cancer Bone Metastasis ImagingProstate Cancer DiagnosisProstate Computed TomographyProstate Disease ImagingWhole-body Magnetic Resonance Imaging
UNLABELLED: Aim of this study was to compare the diagnostic accuracy of positron emission tomography and computed tomography with (11)C-Choline (Cho-PET/CT) and whole body magnetic resonance imaging (WB-MRI) for diagnostic work-up of prostate cancer. PATIENTS, METHODS: We evaluated retrospectively 42 patients with untreated prostate cancer (n = 17), or increasing levels of prostate-specific antigen (PSA) after curative therapy (n = 25) who had been investigated by both Cho-PET/CT and WB-MRI. MRI, CT, and PET images were separately analyzed by experienced radiologists or nuclear medicine experts, followed by consensus reading. Validation was established by histology, follow-up, or consensus reading. RESULTS: 88/103 detected lesions were considered as malignant: 44 bone metastases, 22 local tumor, 15 lymph node metastases, 3 lung, and 3 brain metastases. One further lesion was located in the adrenal gland, which was a second tumor. Overall sensitivity, specificity and accuracy for Cho-PET/CT were 96.6%, 76.5%, and 93.3%, resp., and for WB-MRI 78.4%, 94.1%, and 81.0%, resp. 3 vertebral metastases had initially been missed by Cho-PET/CT and were found retrospectively. MRI identified 2 bone metastases and 1 lymph node metastasis after being informed about the results of Cho-PET/CT. CONCLUSIONS: Cho-PET/CT and WB-MRI both presented high accuracy in the detection of bone and lymph node metastases. The strength of MRI is excellent image quality providing detailed anatomical information whereas the advantage of Cho-PET/CT is high image contrast of pathological foci.
10
Whole-Body Dual-Modality PET/CT and Whole-Body MRI for Tumor Staging in Oncology
Gerald Antoch · JAMA · 2003 · 552 citations
PET imaging of prostate cancer using carbon-11-choline.
Toshihiko Hara, N Kosaka, Hirofumi Kishi · PubMed · 1998 · 520 citations
Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
Igle J. de Jong, Jan Pruim, Philip H. Elsinga et al. · PubMed · 2003 · 265 citations
Imaging prostate cancer with 11C-choline PET/CT.
Sven N. Reske, Norbert M. Blumstein, Bernd Neumaier et al. · PubMed · 2006 · 251 citations